Our mission

We're leading a movement to raise the quality of life of people living with epilepsy, and improve treatment outcomes with more personalized care.

We are driven to deliver “Neureka®!” moments to as many people as possible: that moment when people are able to focus on living their best life, without being defined by their condition. 

Neureka® offers a holistic system of support to help patients, caregivers, and clinicians work together to better manage epilepsy.  

Meet the Neureka® leadership team

We’re a passionate team of patient advocates, medical professionals, data analysts, and entrepreneurs—with deep expertise in digital health.

We're inspired to help improve the quality of life of people living with epilepsy. Working together, there are brighter days ahead!

Ray Iskander
Ray Iskander
CEO + Board Member
Serial Entrepreneur, Data Scientist, Co-founder, Mirametrix (acquired by NASDSAQ:LSCC Lattice Semiconductor) Co-founder, Thirdwayv, CA, USA
Parisa Sabetian, PhD
Parisa Sabetian, PhD
Chief Scientific Officer + Co-Founder
PhD in Biomedical Engineering 7 Years Neuro-Engineering Experience aspects of Epilepsy Young Entrepreneur
Kramay Patel, BASc
Kramay Patel, BASc
Chief Platform Officer
MD/PhD Candidate PhD in Biomedical Engineering and Computational Neuroscience
John Stern, MD
John Stern, MD
Chair of the Scientific Advisory Board
Professor Director, Epilepsy Clinical Program Director, Epilepsy Fellowship Program Co-Director, UCLA Seizure Disorder Center UCLA Department of Neurology

Meet the nEureka® leadership team.

We’re a multidisciplinary team of neuroscientists, data analysts, technology entrepreneurs, patient advocates and more -- with deep expertise in hands-on application within our respective fields.

We firmly believe that we can improve quality-of-life for people living with epilepsy. Working together, there are brighter days ahead!

Ray Iskander
Ray Iskander
CEO + Board Member
Serial Entrepreneur, Data Scientist, Co-founder, Mirametrix (acquired by NASDSAQ:LSCC Lattice Semiconductor) Co-founder, Thirdwayv, CA, USA
Parisa Sabetian, PhD
Parisa Sabetian, PhD
Chief Scientific Officer + Co-Founder
PhD in Biomedical Engineering 7 Years Neuro-Engineering Experience aspects of Epilepsy Young Entrepreneur
Kramay Patel, BASc
Kramay Patel, BASc
Chief Platform Officer
MD/PhD Candidate PhD in Biomedical Engineering and Computational Neuroscience
John Stern, MD
John Stern, MD
Chair of the Scientific Advisory Board
Professor Director, Epilepsy Clinical Program Director, Epilepsy Fellowship Program Co-Director, UCLA Seizure Disorder Center UCLA Department of Neurology

Our company

Novela Neurotech is a digital health company that creates personalized care for chronic neurological conditions. Novela is an FDA-registered facility leading the transformation of remote neurological healthcare.

With a decade of research legacy in neurotechnology and epilepsy at the University of Waterloo in Canada, and deep expertise in digital health and healthcare, Novela is uniquely positioned to transform current episodic neurological care to remote care for millions of people with chronic neurological disorders.

We’re not doing it alone. Guided by the expertise and input from patients, caregivers, and neurologists, we aim to create solutions that speak to their needs of an independent lifestyle, with unbeatable usability and excellence. Neureka® for Epilepsy is just the start. With the Neureka® platform, we aim to improve the lives of millions of people with other neurological conditions.

Neureka® collaborators

By partnering with patient groups and prestigious institutions across the US and Canada, Novela fosters a collaborative environment to develop and improve upon our solutions.

Novela Neurotechnologies, Inc.
Selected company
UCSF 2021 Rosenman Innovators